Arrivo BioVentures

Arrivo BioVentures is a privately held biopharmaceutical development company based in Morrisville, North Carolina. The company focuses on identifying and developing first-in-class or best-in-class biologics and small molecules to treat hard-to-treat diseases by targeting their root causes. Arrivo operates as a holding company that provides management oversight and funding for its subsidiaries, including Sirtsei Pharmaceuticals, Inc. and Panafina, Inc. The company's business model involves sourcing and acquiring development candidates ready for early-stage clinical trials and advancing them through clinical proof-of-concept to achieve significant valuation inflection points.